Institute of Cell Biology and Immunology Thurgau (BITG) at the University of Konstanz, Kreuzlingen, Switzerland.
Division of Immunology, Department of Biology, University of Konstanz, Konstanz, Germany.
Front Immunol. 2024 Aug 23;15:1445338. doi: 10.3389/fimmu.2024.1445338. eCollection 2024.
Defective ribosomal products (DRiPs) are non-functional proteins rapidly degraded during or after translation being an essential source for MHC class I ligands. DRiPs are characterized to derive from a substantial subset of nascent gene products that degrade more rapidly than their corresponding native retiree pool. So far, mass spectrometry analysis revealed that a large number of HLA class I peptides derive from DRiPs. However, a specific viral DRiP on protein level was not described. In this study, we aimed to characterize and identify DRiPs derived from a viral protein.
Using the nucleoprotein (NP) of the lymphocytic choriomeningitis virus (LCMV) which is conjugated N-terminally to ubiquitin, or the ubiquitin-like modifiers FAT10 or ISG15 the occurrence of DRiPs was studied. The formation and degradation of DRiPs was monitored by western blot with the help of a FLAG tag. Flow cytometry and cytotoxic T cells were used to study antigen presentation.
We identified several short lived DRiPs derived from LCMV-NP. Of note, these DRiPs could only be observed when the LCMV-NP was modified with ubiquitin or ubiquitin-like modifiers, but not in the wild type form. Using proteasome inhibitors, we could show that degradation of LCMV-NP derived DRiPs were proteasome dependent. Interestingly, the synthesis of DRiPs could be enhanced when cells were stressed with the help of FCS starvation. An enhanced NP118-126 presentation was observed when the LCMV-NP was modified with ubiquitin or ubiquitin-like modifiers, or under FCS starvation.
Taken together, we visualize for the first time DRiPs derived from a viral protein. Furthermore, DRiPs formation, and therefore MHC-I presentation, is enhanced under cellular stress conditions. Our investigations on DRiPs in MHC class I antigen presentation open up new approaches for the development of vaccination strategies.
缺陷核糖体产物(DRiPs)是在翻译过程中或翻译后迅速降解的非功能蛋白质,是 MHC I 类配体的重要来源。DRiPs 的特点是来源于大量新生基因产物,这些产物的降解速度比相应的天然退休池更快。到目前为止,质谱分析显示大量 HLA I 类肽来源于 DRiPs。然而,尚未在蛋白质水平上描述特定的病毒 DRiP。在这项研究中,我们旨在表征和鉴定源自病毒蛋白的 DRiPs。
使用淋巴细胞性脉络丛脑膜炎病毒(LCMV)的核蛋白(NP),其 N 端与泛素连接,或泛素样修饰物 FAT10 或 ISG15,研究 DRiPs 的发生。通过使用 FLAG 标签的 Western blot 监测 DRiPs 的形成和降解。流式细胞术和细胞毒性 T 细胞用于研究抗原呈递。
我们鉴定了源自 LCMV-NP 的几种短寿命 DRiPs。值得注意的是,只有当 LCMV-NP 被泛素或泛素样修饰物修饰时,才能观察到这些 DRiPs,而在野生型形式下则不能。使用蛋白酶体抑制剂,我们可以证明 LCMV-NP 衍生的 DRiPs 的降解是依赖于蛋白酶体的。有趣的是,当细胞在 FCS 饥饿的帮助下受到应激时,DRiPs 的合成可以增强。当 LCMV-NP 被泛素或泛素样修饰物修饰,或在 FCS 饥饿下时,观察到 NP118-126 的呈递增强。
总之,我们首次可视化了源自病毒蛋白的 DRiPs。此外,DRiPs 的形成,因此 MHC I 呈递,在细胞应激条件下增强。我们对 MHC I 类抗原呈递中 DRiPs 的研究为疫苗策略的发展开辟了新途径。